Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0031515 | tRNA (m1A) methyltransferase complex | 6 | 12 |
GO:0032991 | protein-containing complex | 1 | 12 |
GO:0034708 | methyltransferase complex | 4 | 12 |
GO:0043527 | tRNA methyltransferase complex | 5 | 12 |
GO:1902494 | catalytic complex | 2 | 12 |
GO:1990234 | transferase complex | 3 | 12 |
GO:0005634 | nucleus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AIT3
Term | Name | Level | Count |
---|---|---|---|
GO:0001510 | RNA methylation | 4 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006399 | tRNA metabolic process | 7 | 1 |
GO:0006400 | tRNA modification | 6 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008033 | tRNA processing | 8 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009451 | RNA modification | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0030488 | tRNA methylation | 5 | 1 |
GO:0032259 | methylation | 2 | 1 |
GO:0034470 | ncRNA processing | 7 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034660 | ncRNA metabolic process | 6 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0043414 | macromolecule methylation | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0008168 | methyltransferase activity | 4 | 12 |
GO:0008173 | RNA methyltransferase activity | 4 | 12 |
GO:0008175 | tRNA methyltransferase activity | 5 | 12 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 5 | 12 |
GO:0016426 | tRNA (adenine) methyltransferase activity | 6 | 12 |
GO:0016429 | tRNA (adenine-N1-)-methyltransferase activity | 7 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 12 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 12 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 12 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 179 | 183 | PF00656 | 0.423 |
CLV_NRD_NRD_1 | 154 | 156 | PF00675 | 0.202 |
CLV_NRD_NRD_1 | 305 | 307 | PF00675 | 0.403 |
CLV_PCSK_KEX2_1 | 154 | 156 | PF00082 | 0.209 |
CLV_PCSK_KEX2_1 | 274 | 276 | PF00082 | 0.405 |
CLV_PCSK_KEX2_1 | 304 | 306 | PF00082 | 0.389 |
CLV_PCSK_PC1ET2_1 | 274 | 276 | PF00082 | 0.405 |
CLV_PCSK_PC7_1 | 150 | 156 | PF00082 | 0.238 |
CLV_PCSK_SKI1_1 | 54 | 58 | PF00082 | 0.472 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.377 |
DOC_MAPK_gen_1 | 277 | 287 | PF00069 | 0.457 |
DOC_MAPK_MEF2A_6 | 10 | 18 | PF00069 | 0.497 |
DOC_PP2B_LxvP_1 | 210 | 213 | PF13499 | 0.312 |
DOC_PP4_FxxP_1 | 268 | 271 | PF00568 | 0.388 |
DOC_USP7_MATH_1 | 201 | 205 | PF00917 | 0.450 |
DOC_WW_Pin1_4 | 190 | 195 | PF00397 | 0.401 |
DOC_WW_Pin1_4 | 22 | 27 | PF00397 | 0.360 |
DOC_WW_Pin1_4 | 233 | 238 | PF00397 | 0.289 |
LIG_14-3-3_CanoR_1 | 288 | 292 | PF00244 | 0.443 |
LIG_BRCT_BRCA1_1 | 194 | 198 | PF00533 | 0.197 |
LIG_FHA_1 | 121 | 127 | PF00498 | 0.326 |
LIG_FHA_1 | 23 | 29 | PF00498 | 0.381 |
LIG_FHA_1 | 80 | 86 | PF00498 | 0.328 |
LIG_FHA_1 | 87 | 93 | PF00498 | 0.313 |
LIG_LIR_Apic_2 | 266 | 271 | PF02991 | 0.318 |
LIG_LIR_Gen_1 | 206 | 217 | PF02991 | 0.303 |
LIG_LIR_Gen_1 | 297 | 307 | PF02991 | 0.365 |
LIG_LIR_LC3C_4 | 13 | 18 | PF02991 | 0.507 |
LIG_LIR_Nem_3 | 165 | 170 | PF02991 | 0.324 |
LIG_LIR_Nem_3 | 206 | 212 | PF02991 | 0.303 |
LIG_LIR_Nem_3 | 266 | 272 | PF02991 | 0.361 |
LIG_LIR_Nem_3 | 297 | 302 | PF02991 | 0.346 |
LIG_PDZ_Class_1 | 330 | 335 | PF00595 | 0.757 |
LIG_Pex14_2 | 269 | 273 | PF04695 | 0.466 |
LIG_SH2_STAP1 | 137 | 141 | PF00017 | 0.318 |
LIG_SH2_STAP1 | 93 | 97 | PF00017 | 0.303 |
LIG_SH2_STAT5 | 137 | 140 | PF00017 | 0.318 |
LIG_SH2_STAT5 | 299 | 302 | PF00017 | 0.341 |
LIG_SH2_STAT5 | 55 | 58 | PF00017 | 0.542 |
LIG_SH3_1 | 63 | 69 | PF00018 | 0.492 |
LIG_SH3_3 | 209 | 215 | PF00018 | 0.312 |
LIG_SH3_3 | 63 | 69 | PF00018 | 0.620 |
LIG_SUMO_SIM_anti_2 | 13 | 19 | PF11976 | 0.380 |
LIG_SUMO_SIM_anti_2 | 70 | 75 | PF11976 | 0.334 |
LIG_SUMO_SIM_anti_2 | 94 | 101 | PF11976 | 0.302 |
LIG_WRC_WIRS_1 | 232 | 237 | PF05994 | 0.318 |
LIG_WRC_WIRS_1 | 299 | 304 | PF05994 | 0.319 |
MOD_CK1_1 | 193 | 199 | PF00069 | 0.345 |
MOD_CK1_1 | 290 | 296 | PF00069 | 0.585 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.467 |
MOD_Cter_Amidation | 108 | 111 | PF01082 | 0.450 |
MOD_GlcNHglycan | 118 | 121 | PF01048 | 0.289 |
MOD_GlcNHglycan | 296 | 299 | PF01048 | 0.369 |
MOD_GlcNHglycan | 76 | 79 | PF01048 | 0.337 |
MOD_GSK3_1 | 114 | 121 | PF00069 | 0.303 |
MOD_GSK3_1 | 122 | 129 | PF00069 | 0.303 |
MOD_GSK3_1 | 290 | 297 | PF00069 | 0.422 |
MOD_N-GLC_1 | 22 | 27 | PF02516 | 0.416 |
MOD_N-GLC_2 | 133 | 135 | PF02516 | 0.236 |
MOD_N-GLC_2 | 221 | 223 | PF02516 | 0.423 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.532 |
MOD_NEK2_1 | 122 | 127 | PF00069 | 0.318 |
MOD_NEK2_1 | 162 | 167 | PF00069 | 0.388 |
MOD_NEK2_1 | 231 | 236 | PF00069 | 0.318 |
MOD_NEK2_1 | 239 | 244 | PF00069 | 0.318 |
MOD_NEK2_1 | 287 | 292 | PF00069 | 0.560 |
MOD_PIKK_1 | 162 | 168 | PF00454 | 0.423 |
MOD_PIKK_1 | 239 | 245 | PF00454 | 0.303 |
MOD_PIKK_1 | 79 | 85 | PF00454 | 0.308 |
MOD_PIKK_1 | 86 | 92 | PF00454 | 0.295 |
MOD_PK_1 | 67 | 73 | PF00069 | 0.524 |
MOD_PKA_2 | 287 | 293 | PF00069 | 0.508 |
MOD_PKA_2 | 4 | 10 | PF00069 | 0.407 |
MOD_Plk_2-3 | 258 | 264 | PF00069 | 0.303 |
MOD_Plk_4 | 287 | 293 | PF00069 | 0.490 |
MOD_Plk_4 | 67 | 73 | PF00069 | 0.449 |
MOD_ProDKin_1 | 190 | 196 | PF00069 | 0.397 |
MOD_ProDKin_1 | 22 | 28 | PF00069 | 0.361 |
MOD_ProDKin_1 | 233 | 239 | PF00069 | 0.289 |
MOD_SUMO_rev_2 | 311 | 319 | PF00179 | 0.469 |
TRG_DiLeu_BaEn_1 | 68 | 73 | PF01217 | 0.553 |
TRG_DiLeu_BaEn_4 | 314 | 320 | PF01217 | 0.478 |
TRG_ENDOCYTIC_2 | 299 | 302 | PF00928 | 0.341 |
TRG_ER_diArg_1 | 153 | 155 | PF00400 | 0.202 |
TRG_ER_diArg_1 | 304 | 306 | PF00400 | 0.369 |
TRG_NES_CRM1_1 | 96 | 107 | PF08389 | 0.197 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PA18 | Leptomonas seymouri | 83% | 100% |
A0A0S4IUX6 | Bodo saltans | 59% | 95% |
A0A1X0NRB0 | Trypanosomatidae | 64% | 98% |
A0A3Q8IIA8 | Leishmania donovani | 89% | 95% |
A0A3R7LPM7 | Trypanosoma rangeli | 63% | 100% |
A4I3X1 | Leishmania infantum | 89% | 95% |
A6H791 | Bos taurus | 36% | 100% |
D0A938 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 61% | 80% |
E9B061 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 95% |
O14307 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 35% | 92% |
P0CS08 | Cryptococcus neoformans var. neoformans serotype D (strain JEC21 / ATCC MYA-565) | 37% | 77% |
P0CS09 | Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) | 37% | 77% |
P46959 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 35% | 87% |
P9WFZ0 | Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) | 30% | 100% |
P9WFZ1 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 30% | 100% |
Q4Q824 | Leishmania major | 88% | 100% |
Q4WUT7 | Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) | 29% | 67% |
Q57598 | Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) | 28% | 100% |
Q5A416 | Candida albicans (strain SC5314 / ATCC MYA-2876) | 35% | 100% |
Q6AY46 | Rattus norvegicus | 36% | 100% |
Q6BX32 | Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) | 33% | 91% |
Q6C0P9 | Yarrowia lipolytica (strain CLIB 122 / E 150) | 33% | 86% |
Q6CN53 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) | 35% | 82% |
Q6FL77 | Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) | 33% | 90% |
Q755M8 | Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | 38% | 83% |
Q80XC2 | Mus musculus | 36% | 100% |
Q86JJ0 | Dictyostelium discoideum | 32% | 100% |
Q96FX7 | Homo sapiens | 36% | 100% |
Q9V1J7 | Pyrococcus abyssi (strain GE5 / Orsay) | 26% | 100% |
V5BC39 | Trypanosoma cruzi | 62% | 100% |